X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (66502) 66502
Book Review (8942) 8942
Publication (3932) 3932
Newsletter (786) 786
Book Chapter (260) 260
Book / eBook (150) 150
Conference Proceeding (100) 100
Newspaper Article (96) 96
Dissertation (73) 73
Magazine Article (55) 55
Transcript (6) 6
Reference (4) 4
Trade Publication Article (3) 3
Data Set (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56453) 56453
humans (53475) 53475
female (31876) 31876
male (29254) 29254
middle aged (26697) 26697
oncology (25816) 25816
cancer (23220) 23220
aged (22872) 22872
adult (17987) 17987
carcinoma (13160) 13160
metastasis (12712) 12712
squamous cell carcinoma (12407) 12407
prognosis (11742) 11742
carcinoma, squamous cell - pathology (10504) 10504
tumors (10501) 10501
surgery (10371) 10371
aged, 80 and over (9696) 9696
expression (9416) 9416
squamous-cell carcinoma (8823) 8823
animals (8673) 8673
chemotherapy (8630) 8630
care and treatment (8544) 8544
neoplasm staging (8448) 8448
carcinoma, squamous cell - secondary (8395) 8395
immunohistochemistry (8385) 8385
analysis (8255) 8255
cell line, tumor (8213) 8213
research (8183) 8183
apoptosis (7301) 7301
retrospective studies (6698) 6698
proteins (6475) 6475
pathology (6473) 6473
health aspects (6289) 6289
lung neoplasms - pathology (6252) 6252
gene expression (6106) 6106
treatment outcome (6058) 6058
lymphatic metastasis (5963) 5963
survival (5879) 5879
abridged index medicus (5633) 5633
development and progression (5626) 5626
radiotherapy (5571) 5571
carcinoma, squamous cell - surgery (5552) 5552
mice (5447) 5447
lung cancer (5375) 5375
medicine & public health (5092) 5092
genetic aspects (5041) 5041
survival rate (4808) 4808
follow-up studies (4620) 4620
head (4561) 4561
gene expression regulation, neoplastic (4484) 4484
cell biology (4479) 4479
risk factors (4325) 4325
medical prognosis (4278) 4278
diagnosis (4273) 4273
breast-cancer (4259) 4259
cell proliferation (4225) 4225
cancer therapies (3958) 3958
otorhinolaryngology (3873) 3873
carcinoma, squamous cell - metabolism (3867) 3867
neoplasm invasiveness (3717) 3717
patients (3624) 3624
adenocarcinoma (3568) 3568
metastases (3483) 3483
kinases (3451) 3451
studies (3396) 3396
medicine (3355) 3355
carcinoma, squamous cell - mortality (3290) 3290
hematology, oncology and palliative medicine (3261) 3261
proliferation (3219) 3219
signal transduction (3219) 3219
research article (3217) 3217
survival analysis (3210) 3210
biochemistry & molecular biology (3203) 3203
carcinoma, squamous cell - genetics (3199) 3199
carcinoma, non-small-cell lung - pathology (3196) 3196
lung cancer, non-small cell (3189) 3189
invasion (3176) 3176
growth (3163) 3163
disease-free survival (3162) 3162
breast cancer (3128) 3128
esophageal cancer (3111) 3111
carcinoma, squamous cell - drug therapy (3108) 3108
cancer research (3104) 3104
medicine, research & experimental (3102) 3102
therapy (3093) 3093
cell cycle (3086) 3086
antineoplastic combined chemotherapy protocols - therapeutic use (3078) 3078
neck (2998) 2998
radiology, nuclear medicine & medical imaging (2972) 2972
combined modality therapy (2966) 2966
lung neoplasms - drug therapy (2949) 2949
head and neck neoplasms - pathology (2916) 2916
cell growth (2897) 2897
carcinoma, squamous cell - therapy (2874) 2874
carcinoma, squamous cell - radiotherapy (2833) 2833
head and neck cancer (2823) 2823
medical research (2800) 2800
article (2786) 2786
esophageal neoplasms - pathology (2723) 2723
dentistry, oral surgery & medicine (2668) 2668
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (116) 116
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Humber River Regional Hospital - Finch Stacks (4) 4
Gerstein Science - Circulation Desk (3) 3
St. Michael's Hospital - Stacks (3) 3
Gerstein Science - Reference (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Credit Valley Hospital - Special Collections (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Markham Stouffville Hospital - Storage (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Stacks (1) 1
Physics - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (65790) 65790
Japanese (504) 504
French (355) 355
German (342) 342
Chinese (262) 262
Spanish (173) 173
Polish (113) 113
Italian (81) 81
Russian (76) 76
Portuguese (28) 28
Korean (20) 20
Turkish (18) 18
Dutch (17) 17
Hungarian (11) 11
Czech (10) 10
Danish (10) 10
Serbian (8) 8
Romanian (7) 7
Croatian (5) 5
Hebrew (4) 4
Icelandic (3) 3
Slovak (3) 3
Norwegian (2) 2
Swedish (2) 2
Arabic (1) 1
Bulgarian (1) 1
Finnish (1) 1
Greek (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 516 - 524
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 4, pp. 341 - 351
Among patients with advanced cutaneous squamous-cell carcinoma, the PD-1 inhibitor cemiplimab induced a response in approximately half the patients and was... 
MISMATCH-REPAIR DEFICIENCY | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | NONMELANOMA SKIN-CANCER | SOLID TUMORS | LANDSCAPE | SENSITIVITY | CONSENSUS | TUMOR MUTATIONAL BURDEN | GUIDELINE | Skin Neoplasms - pathology | Skin Neoplasms - drug therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Dose-Response Relationship, Drug | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Agents - adverse effects | Immunotherapy | Aged, 80 and over | Adult | Carcinoma, Squamous Cell - secondary | Female | Aged | Programmed Cell Death 1 Receptor - immunology | Neoplasm Staging | Monoclonal antibodies | Squamous cell carcinoma | Dosage and administration | Safety and security measures | Drug therapy | Intravenous administration | PD-1 protein | Body weight | Oncology | Metastasis | Cancer therapies | Metastases | Surgery | Constipation | Drug dosages | Departments | Statistical analysis | Dermatology | Diarrhea | Fatigue | Nausea | Patients | Medicine | Studies | Immunosuppression | Hospitals | Immune checkpoint | Womens health | Response rates | Skin | Health risk assessment | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2030 - 2037
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 8, pp. 713 - 720
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 10/2015, Volume 22, Issue 11, pp. 3708 - 3715
Journal Article